Clover Health Investments, Corp

Day range

$4.64 – $4.80

Open

$4.77

Prev close

$4.73

Volume

3.19M

Market cap

$2.51B

Shares out

435.44M

P/E

—

P/S

1.01

P/B

6.68

P/FCF

33.86

ROE

-4.9%

ROA

-2.5%

Debt/Equity

0.67

Div yield

0.00%

As of Oct 22, 2026

• Investor communicationsOct 9, 2026

  On October 8, 2026, Clover Health Investments, Corp. issued a press release commenting on the Centers for Medicare & Medicaid Services release of its 2027 Star Ratings for the Company's Medicare Advantage plans.

• Executive leadershipSep 24, 2026

  In connection with their service as directors during 2026, Senator Torricelli and Dr. Miller will each receive a pro rata portion of the annual retainer for service on the Board, Audit Committee and Clinical Committee, as applicable, under Clover's Amended and Restated Director Compensation Policy. Senator Torricelli and Dr. Miller will also each be granted a restricted stock unit ("RSU") award covering shares of the Company's Class A Common Stock having an RSU value of $200,000, pro-rated by multiplying such amount by a fraction, the numerator of which is the number of days of service that each of Senator Torricelli and Dr. Miller will provide from the date of his appointment until December 31, 2026, and the denominator of which is 365 days.

• Investor communicationsAug 20, 2026

  On August 20, 2026, Clover Health Investments, Corp. (the "Company") published a list of responses to a selection of frequently asked supplemental questions submitted in connection with the Company's second quarter 2026 earnings announcement in order to further engagement with the Company's shareholder base.

• Security and safetyJul 17, 2026

  On July 4, 2026, Clover Health Investments, Corp. (the "Company") became aware of anomalous login activity on certain of its information systems. The Company immediately activated its incident response procedures, initiated an investigation with assistance from leading third-party cybersecurity experts, and took steps to contain the activity. The investigation subsequently showed that a threat actor gained access to three non-managerial health plan employee accounts through social engineering.

• Business developmentsJun 18, 2026

  CMS informed Clover Health Investments, Corp. that, consistent with a court judgment in Clover Insurance Co. V. HHS, CMS had recalculated the 2026 Star Rating for the Company's PPO Medicare Advantage contract, H5141, from 3.5 Stars to 4.5 Stars for payment year 2027.

Days to cover

6.3

Short interest

22.9M

Avg volume

3.63M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Global Insurtech Market Size, Share, Trends, and Forecast to 2035 | AI, Cloud, and Automation Drive 41.45% CAGR, Creating a USD 638 Billion Opportunity
  positiveGlobeNewswire Inc.· Oct 9, 2026
• Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
  positiveGlobeNewswire Inc.· Oct 8, 2026
• UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors
  positiveGlobeNewswire Inc.· Sep 24, 2026
• Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors
  positiveGlobeNewswire Inc.· Sep 24, 2026
• Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.
  neutralThe Motley Fool· Jul 31, 2026